Aralez Pharmaceuticals Inc (TSE:ARZ)’s share price was up 2.7% during mid-day trading on Friday . The company traded as high as C$1.87 and last traded at C$1.80. Approximately 39,800 shares traded hands during mid-day trading, a decline of 6% from the average daily volume of 42,161 shares. The stock had previously closed at C$1.85.
TRADEMARK VIOLATION WARNING: “Aralez Pharmaceuticals (ARZ) Trading Up -2.7%” was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/12/17/aralez-pharmaceuticals-arz-trading-up-2-7.html.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.